The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, SunEdison, HMS Holdings, Abercrombie

Mon, 24th Aug 2015 17:10

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock indexes were down on Monday. The Dow Jones industrialaverage was down 0.76 percent at 16,333.98, the S&P 500 was down 0.96 percent at 1,952.06 and the NasdaqComposite was down 0.92 percent at 4,662.53.

For a Breakingviews column, Investors' self-doubt worsensequity woes

** APPLE INC, $108.0301, +2.15 pct

The iPhone maker's shares rebounded sharply off day's lows,helping U.S. stocks stage a dramatic recovery. The shares openedmore than 10 percent lower in heavy trading. Stock still off afifth from February's record high.

For a Breakingviews column, Tech's real China syndromevictims are yet to fall

** BANK OF AMERICA CORP, $15.96, -0.87 pct

** CITIGROUP INC, $52.42, -2.20 pct

** MORGAN STANLEY, $33.47, -2.16 pct

** JPMORGAN CHASE & CO, $62.78, -1.29 pct

** GOLDMAN SACHS GROUP INC, $186.43, -0.70 pct

** WELLS FARGO & CO, $53.05, -1.70 pct

U.S. bank stocks continued to slide after last week's Fedminutes suggested the central bank may not raise interest ratesin September due to international developments, including weakeryuan.

Traders now see a 24 percent chance that Fed will increaserates in September, down from 30 percent late on Friday and 46percent a week earlier, according to Tullett Prebon data.

** NETFLIX INC, $106.57, +2.51 pct

** GENERAL MOTORS CO, $28.77, -2.80 pct

** TESLA MOTORS INC, $229.73, -0.45 pct

** CATERPILLAR INC, $74.67, -0.44 pct

** UNITED STATES STEEL CORP, $16.09, +1.13 pct

** ALCOA INC, $8.53, -2.29 pct

** YUM BRANDS, $78.61, -1.37 pct

Shares of U.S. companies fell at the open on China worries,though a handful of tech stocks were fighting against thebroadly weak market.

** SOLARCITY, $46.8701, +14.35 pct

** SUNEDISON INC, $11.61, +8.30 pct

The stocks snapped back from sharp plunges, with SolarCityup 11.5 percent after being down 15 percent in early trading.The relief rally comes one day after hedge fund manager JimChanos of Kynikos Associates said he was "short SolarCityshares" and criticized both companies' business models.

** ALIBABA GROUP HOLDING LTD, $66.92, -1.85 pct

** JD.COM INC, $24.765, -1.14 pct

** BAIDU INC, $144.395, -5.57 pct

** SINA CORP, $35.28, -2.65 pct

** YOUKU TUDOU, $16.18, -3.75 pct

** YY INC, $54.96, -7.19 pct

** CHINA DANGDANG, $6.3, -4.83 pct

** JUMEI INTERNATIONAL HOLDING, $10.78, -8.33 pct

U.S.-listed shares of Chinese technology companies fellafter Chinese indexes post their biggest one-day percentagelosses since the height of the financial crisis.

** EXXON MOBIL CORP, $70.82, -1.82 pct

** CONOCOPHILLIPS, $44.77, -1.37 pct

** CHEVRON CORP, $74.94, -1.08 pct

Oil prices fell more than 6 percent to fresh 6-1/2-year lowsas markets worried about a China-led global economic slowdownthat would drastically hit oil consumption at a time ofplentiful supply.

S&P 500 oil & gas, oilfield services companies havealready lost about $310 billion in market value this year.

For a Breakingviews column, Oil has room to get even moreirrational

** GLAXOSMITHKLINE PLC, $1,270.53703, -3.21 pct

** MERCK & CO, $54.81, -1.72 pct

** JOHNSON & JOHNSON, $95, -0.59 pct

** BIOGEN INC, $294.82, -0.28 pct

** CELGENE CORP, $118.59, -0.39 pct

** ELI LILLY & CO, $82.76, -2.09 pct

** BRISTOL-MYERS SQUIBB CO, $60.88, -0.31 pct

** PFIZER INC, $33.21 -0.98 pct

** AMGEN INC, $153.58 -1.04 pct

** GILEAD SCIENCES INC, $106.08 +0.71 pct

The S&P 500 Healthcare sector index declined 3percent to 801.97, Nasdaq Biotechnology index down nearly4 percent at 3436.71

** OCATA THERAPEUTICS INC, $4.5816 +20.25 pct

The drug developer awarded Small Business InnovationResearch grant from National Institute of Allergy and InfectiousDiseases, part of National Institutes of Health.

** EPIZYME INC, $18.9 +18.64 pct

The drug developer said U.S. Food and Drug Administrationaccepted its application to start clinical studies of its leadcancer drug, Tazemetostat.

** HMS HOLDINGS CORP, $10.73 +21.38 pct

The New York State Office of the Medicaid Inspector Generalawarded the healthcare facility provider a contract for Medicaidthird-party liability match and recovery services.

** HUBBELL INC, $113.25 +22.68 pct

The electrical equipment maker said it plans to reclassifycommon stock to eliminate its existing two-class structure.

** GEVO INC, $2.54 +10.92 pct

The chemical maker and Butamax Advanced Biofuels LLC, ajoint venture between BP and DuPont, ended apatent dispute related to the production of bio-based fueladditive, isobutanol, and entered into cross-license andsettlement agreements.

** ABERCROMBIE & FITCH CO, $17.58 +6.87 pct

Piper Jaffray upgrades the apparel retailer's stock to"overweight" from "neutral" and raises price target by $2 to$27.

** AGL RESOURCES INC, $62.01, +29.57 pct

** SOUTHERN CO, $44.58, -2.66 pct

Power producer Southern said it would buy AGL Resources forabout $8 billion in cash to become the No. 2 U.S. utility bycustomers after Exelon Corp.

** VITAL THERAPIES INC, $4.02, -77.26 pct

The drug developer said it would stop two ongoing trialstesting its cell-therapy, ELAD, after it failed a late-stagestudy in liver failure patients.

** CHINACACHE INTERNATIONAL HOLDINGS LTD, $6.02,+7.69 pct

The China-based network service provider plans to buy backup to $6 million worth of outstanding ADSs over the next 12months. This is in addition to ChinaCache's existing $10 millionshare buyback.

** EXELIXIS INC, $5.455, +3.90 pct

The U.S. FDA granted the drugmaker's lead drug,cabozantinib, "breakthrough therapy" status to treat patientswith the most common form of kidney cancer.

(Compiled by Arunima Banerjee in Bengaluru; Editing by SrirajKalluvila)

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.